Human Biobanking Ownership - Global Trends, Estimates And Forecasts To 2020

Global Market Watch:

Primarily supported by ownership types; Private Biobanks and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to witness a value of US$37.1 billion by 2020. Geographical analysis for Private Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from Asia-Pacific region during the analysis period 2014-2020. North America is not way behind with a CAGR of 9.95% followed by Europe at 9.56% respectively.

Report Focus:

The report “Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

Emerging market trends
Advancements in the technological space
Market demand of the segments (by-region)
Key growth areas and market size
Key competitor’s Edge
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with human biobanking ownership market. Further, the subdivided categories include:

Private Banks
a. Disease-Based Banks
b. Population-Based Banks
c. Academics
Public Banks1
a. Disease-Based Banks
b. Population-Based Banks
c. Academics
Hospitals, Biotechnology & Pharmaceutical Companies, Diagnostics, Transplantation and Biobank Storage Companies
Newborns, Adults or Pregnant Women
Medical Institutions, Research and Forensics
The period considered for the human biobanking ownership market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 1270 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/715364

List of Key Companies

North America

Vericel Corporation
Acorda Therapeutics, Inc.
Alpha Cord, Inc.
Affymetrix, Inc.
Cellerant Therapeutics, Inc.
Cryo-Cell International, Inc.
Mesoblast, Inc.
Atgc Labs
Autogen, Inc.
Barber Nichols
Beckman Coulter, Inc.
Biocision
U.S. Stem Cell, Inc.
Biolife Solutions, Inc.
Biological Specimen Inventory System
Biomatrica, Inc.
Biostorage, Llc.
Cti Biopharma Corp.
Chart Industries, Inc.
Charter Medical, Ltd.
Corcell, Inc.
Cord Blood Registry
Core Dynamics (Usa), Inc.
Cryolife, Inc.
Cryomagnetics, Inc.
Cryoplus, Inc.
Cryoxtract
Custom Biogenic Systems
Dataworks Development, Inc.
Dna Genotek, Inc.
Epl Archieves, Inc.
Genzyme Corp.
Gilead Sciences, Inc.
Hamilton Storage Technologies
Labvantage Solutions, Inc.
Labware, Inc.
Lifenet Health
Caladrius Biosciences, Inc.
Eppendorf, Inc.
Novare Biologistics
Origen Biomedical, Inc.
Osiris Therapeutics, Inc.
Pacific Bio-Material Management, Inc.
Promeddx, Llc
Provia Laboratories, Llc
Qiagen Nv
Rand Corporation
Ruro
Seracare Life Sciences
Scientific Instruments, Inc.
Sp Scientific
Spectrocell, Inc.
Abbott Laboratories
Steelgate, Inc.
Trillium Therapeutics, Inc.
Stem Cells, Inc.
Stemcell Technologies, Inc.
Lifeline® Cell Technology
Thermo Fisher Scientific, Inc.
Cesca Therapeutics, Inc.
Trans-Hit Biomarkers, Inc.
Vaisala, Inc.
Viacord
Vital Therapies, Inc.
Wheaton Science Products, Inc.
Europe

Panasonic Biomedical Sales Europe B.V
Epistem Ltd.
Aqix
B & C Group
Bbmri
Lifegene
Biobank Ireland Trust
Biokryo Gmbh
Biorep Srl P.Iva
Biostorage Technologies, Inc.
Boehringer Ingelheim, Gmbh
Cells4life, Ltd.
Cryo Bio System
Cryo-Save, Ag
Decode Genetics
Ge Healthcare Life Sciences
Genesisbps
Highres Biosolutions
Indivumed
Lifegene Biobank
Lifelines Cohort And Biobank (Lifelines)
Linde Gas Cryoservices B.V.
Modul-Bio Sas
Mts Cryostores Uk Ltd
Noray Bioinformatics S.L.U.
Reneuron Group Plc
Sanofi Aventis
Soventec Gmbh
Stirling Cryogenics & Refrigeration Bv
Tecan
Tissue Solutions
UK Stem Cell Bank
Asia-Pacific

Cole Parmer Instrument, Co.
Cordlife Pte., Ltd.
Cryocord Sdn.Bhd.
Cryologic Pty. Ltd.
Genesearch
Ocimum Biosolutions
Reliance Life Sciences
China Cord Blood Corporation
Rest of World

Babycell Egypt
Gamida Cell Ltd.

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.